Printer Friendly

SYNCOR OPENS POSITRON EMISSION TOMOGRAPHY CENTER AND EXPANDS NATIONAL PHARMACY NETWORK

 SYNCOR OPENS POSITRON EMISSION TOMOGRAPHY CENTER
 AND EXPANDS NATIONAL PHARMACY NETWORK
 CHATSWORTH, Calif., Feb. 25 /PRNewswire/ -- Syncor International Corporation (NASDAQ: SCOR) announced today its expansion plans for the first half of 1992 beginning with the opening of a nuclear pharmacy specializing in Positron Emission Tomography (PET) radiopharmaceuticals at the University of Southern California (USC) in Los Angeles. While this is the Syncor's second joint venture with PET technology, it is the first in a university setting. The company's plans for expansion also include the start-up of five additional radiopharmacies in key locations in the United States.
 The start-up costs associated with the expansion of Syncor's national pharmacy network will slightly depress margins for fiscal year 1992 ending May 30. However, overall business continues to be very strong and management is confident that analysts' current earnings estimates for fiscal year 1992 will be achieved.
 During a recent interview, Peter Conti, M.D., Ph.D., director of the University of Southern California PET Imaging Science Center stated "Positron emission tomography is a noninvasive imaging procedure that provides metabolic information that no other imaging modality offers. PET's ability to assess specific tissue function contributes to improved patient diagnosis and more cost effective use of health care dollars."
 Gene McGrevin, Syncor's president and CEO, explained the significance of the two joint ventures in PET. "We have positioned the company to play a leading role in supplying the medical community with prescription drugs using this technology. Our two joint venture will supply market information to help us evaluate the commercial viability of this new specialty."
 McGrevin also said, "Syncor plans to continue to expand its nationwide pharmacy network through a combination of acquisitions and start-ups. We expect to have 100 nuclear pharmacy centers operating by the end of 1992. Our goal is to strengthen our market position in anticipation of new product introductions from the biotechnology industry."
 Syncor International operates a nationwide network of 90 nuclear pharmacy centers and 14 home care pharmacies. The company prepares and delivers patient-specific intravenous drugs and solutions for use in diagnostic imaging and a complete range of products for home infusion therapy. Syncor services over 5,000 hospitals, clinics, physicians' offices, nursing facilities and home-based patients. The only national pharmacy network of its kind, Syncor is unique in combining diagnostic, therapeutic and monitoring services for both hospitals and alternate- site markets.
 -0- 2/25/92
 /CONTACT: John K. Watkins of Syncor, 818-886-7400, or Susan Noonan or Anthony J. Russo of Noonan Russo Communications, 212-979-9180, for Syncor/
 (SCOR) CO: Syncor International Corporation ST: California IN: MTC SU: JVN


SM-TS -- NY006 -- 2181 02/25/92 08:30 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 25, 1992
Words:437
Previous Article:IBM INTRODUCES INDUSTRY'S FASTEST 386SX SYSTEMS; EXCLUSIVE TECHNOLOGY KEEPS PS/2 AHEAD OF THE PACK
Next Article:EnaTec SOFTWARE SYSTEMS STARTS OPERATIONS
Topics:


Related Articles
SYNCOR COMMITS TO JOINT TRAINING PROGRAM WITH UNIVERSITY OF NEW MEXICO AND EXPANDS DISTRIBUTION NETWORK TO ALBUQUERQUE, N.M.
SYNCOR APPOINTS HENRY N. WAGNER, JR., M.D. TO BOARD OF DIRECTORS
SYNCOR ANNOUNCES RECORD FIRST QUARTER RESULTS
SYNCOR WINS CONTRACTS TO PROVIDE RADIOPHARMACEUTICAL SERVICES TO AMERINET AND GALEN HEALTH CARE
SYNCOR SIGNS LETTER OF INTENT TO SELL HOME INFUSION BUSINESS; W.R. GRACE & CO. TO PURCHASE EIGHT HOME CARE SITES
SYNCOR COMPLETES SALE OF HOME INFUSION BUSINESS
MSU, Syncor Collaborate on PET Cyclotron Project.
Nationally, Pharmacist Pay Continues to Rise -- Increasing Recruitment And Retention Pressures on Employers; Based Upon the Recently Released Fall...
Syncor Stockholders Approve Acquisition by Cardinal Health.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters